screening

(redirected from Cervical cytology)
Also found in: Dictionary, Thesaurus, Medical, Encyclopedia.

Screen Stocks

To investigate stocks for potential investment according to a predetermined set of criteria. For example, an investor may screen stocks according to the lowest price, the most market capitalization, the most favorable price-earnings ratio, or any number of other variables. One may also combine criteria while screening stocks. The process is designed to help one make the best investment decisions, and is often accomplished with the help of a computer.

screening

the process of evaluating product ideas in terms of consumer acceptance, technical feasibility and cost. See NEW PRODUCT DEVELOPMENT.
References in periodicals archive ?
The clinician's view of HPV: Role in the ASCCP Guidelines for the Management of Abnormal Cervical Cytology and Cervical Cancer Precursors: ASCUS, LSIL, and Post-Colposcopy [less than or equal to] CIN 1.
The median unsatisfactory cervical cytology rate increased to 0.9% in 2006, compared with the 2003 rate of 0.5% for all methods combined.
For example, it is now known that cervical dysplasia takes several years to develop after infection with human papilloma virus (HPV), so ACOG is recommending that a young woman's first cervical cytology test be performed at age 21 or approximately 3 years after first sexual intercourse, whichever comes first.
NHS England Midlands and East (Leicestershire and Lincolnshire) Cervical Cytology Laboratory service for the Lincolnshire Area.
"Nevertheless, on the basis of our findings, we suggest that detection of HPV-16, HPV-18, or both combined with a raised threshold of abnormal cervical cytology (LSIL or worse) might be preferable to the existing recommendations for management of HPV-positive women," according to the investigators.
Prequalification are invited for Provision of a Cervical Cytology Service to Nobles (Isle of Man) Hospital
In 2019, Techcyte will reportedly deliver solutions for blood analysis, cervical cytology as well as bacteriology.
Anil Jaasinghe, Director General of Health Services at the Ministry of Health, Nutrition and Indigenous Medicine, stated, "An objective of the strategic plan is to shift from cervical cytology tests to HPV testing as a more effective method for cervical cancer screening.
Based on the latest evidence and the modeling study, the USPSTF gives an A recommendation to screening women aged 21-29 years for cervical cancer every 3 years with cervical cytology alone.
Primary screening with cervical cytology alone remains an option supported by many authorities and professional society guidelines.
The cost-effectiveness analysis from the ARTISTIC trial suggests that hrHPV screening would be more cost-effective compared with cervical cytology screening.